Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q4 Operating Result SEK 9.9 Mln

Feb 21 (Reuters) - Kancera AB  KANC.ST :
    * Q4 OPERATING RESULT FOR QUARTER -9.9 MSEK
    * Q4 RESEARCH AND DEVELOPMENT COSTS AMOUNTED TO 8.5 MSEK

Source text:  ID:nMFNH6nN4 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news